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Abstract
Background: Quantitative relaxation time measurements by cardiovascular magnetic resonance (CMR) are of
paramount importance in contrast-enhanced studies of experimental myocardial infarction. First, compared to
qualitative measurements based on signal intensity changes, they are less sensitive to specific parameter choices,
thereby allowing for better comparison between different studies or during longitudinal studies. Secondly, T1
measurements may allow for quantification of local contrast agent concentrations. In this study, a recently
developed 3D T1 mapping technique was applied in a mouse model of myocardial infarction to measure
differences in myocardial T1 before and after injection of a liposomal contrast agent. This was then used to assess
the concentration of accumulated contrast agent.
Materials and methods: Myocardial ischemia/reperfusion injury was induced in 8 mice by transient ligation of the
LAD coronary artery. Baseline quantitative T1 maps were made at day 1 after surgery, followed by injection of a
Gd-based liposomal contrast agent. Five mice served as control group, which followed the same protocol without
initial surgery. Twenty-four hours post-injection, a second T1 measurement was performed. Local ΔR1 values were
compared with regional wall thickening determined by functional cine CMR and correlated to ex vivo Gd
concentrations determined by ICP-MS.
Results: Compared to control values, pre-contrast T1 of infarcted myocardium was slightly elevated, whereas T1 of
remote myocardium did not significantly differ. Twenty-four hours post-contrast injection, high ΔR1 values were
found in regions with low wall thickening values. However, compared to remote tissue (wall thickening > 45%),
ΔR1 was only significantly higher in severe infarcted tissue (wall thickening < 15%). A substantial correlation (r =
0.81) was found between CMR-based ΔR1 values and Gd concentrations from ex vivo ICP-MS measurements.
Furthermore, regression analysis revealed that the effective relaxivity of the liposomal contrast agent was only
about half the value determined in vitro.
Conclusions: 3D cardiac T1 mapping by CMR can be used to monitor the accumulation of contrast agents in
contrast-enhanced studies of murine myocardial infarction. The contrast agent relaxivity was decreased under in
vivo conditions compared to in vitro measurements, which needs consideration when quantifying local contrast
agent concentrations.
Background
Mouse models of myocardial infarction are widely used
to investigate the cascade of events occurring after myo-
cardial ischemia/reperfusion injury. Cardiovascular mag-
netic resonance (CMR) has proven to be the modality of
choice for such studies, as it can produce high-resolu-
tion information on both global and local indices of car-
diac pathology [1-3]. Also, MRI contrast agents are
increasingly applied as they allow monitoring of various
kinds of disease-related processes on cellular and even
molecular level, such as cell death, inflammation and
fibrosis [4-6].
For commonly used T1-weighted imaging, the accu-
mulation of paramagnetic contrast agent is associated
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intensity is an indirect and qualitative measure of con-
centration, because it is influenced by several other fac-
tors, such as coil sensitivities, gain calibration, sequence
timing parameters and fluctuations in ECG- or respira-
tory triggering intervals. Consequently, there is a grow-
ing interest for the application of T1 mapping protocols
in contrast-enhanced studies of myocardial infarction
using T1 contrast agents. Bohl et al. [7] used a Look-
Locker T1 mapping method to rapidly measure changes
in T1 in both remote and infarct areas after injection of
Gd-DTPA. Quantitative knowledge of T1 was translated
to the inversion time that resulted in optimal contrast
in late Gd enhancement (LGE) imaging. Similar imple-
mentations of this method have also been used to dyna-
mically measure T1 after infusion of Mn
2+,a ni o nt h a t
acts as a Ca
2+ analogue, to report on Ca
2+ handling
[8,9].
In this study, we investigated whether quantitative T1
measurements can also serve for the assessment of local
contrast agent concentrations. This is particularly valu-
able for molecular imaging, where one aims to relate
local amounts of contrast agent to the presence of certain
disease markers. We recently presented a novel imaging
protocol for measuring mouse myocardial T1 with
whole-heart coverage, based on retrospective triggering
and variable flip angle analysis [10]. Good reproducibility
of measuring regional T1 was found between measure-
ments at successive days; however, limited data was avail-
able concerning changes in T1 in infarcted myocardium
upon injection of a Gd-based contrast agent. Here, we
hypothesize that this method provides an accurate read-
out of regional contrast agent induced changes of myo-
cardial T1 in a mouse model of ischemia/reperfusion
injury and allows for determination of local contrast
agent concentrations. To test this hypothesis, we mea-
sured the accumulation of a liposomal contrast agent
after myocardial ischemia/perfusion injury and quantified
local changes in T1 using three-dimensional T1 mapping.
Then, ΔR1 values derived from pre- and post-contrast in
vivo T1 maps were correlated to contrast agent concen-
trations obtained from ex vivo inductively coupled
plasma mass spectrometry (ICP-MS).
The use of a liposomal contrast agent allowed for T1
measurements several hours after contrast agent injec-
tion at a time point at which the contrast agent was
almost cleared from the blood circulation and did not
contaminate the measurement of myocardial T1.I nt h i s
application, myocardial contrast agent concentrations
were stable for an extended period of time, which
increased the available imaging time and allowed for full
3D coverage of the heart. Moreover, the use of lipo-
s o m e si nt h i se x p e r i m e n t a l mouse model of myocardial
infarction provided the opportunity to perform relevant
validation experiments concerning in vivo quantification
of the actual contrast agent concentration and relaxivity
properties in the heart.
Materials and methods
Contrast agent preparation and characterization
Preparation
Paramagnetic liposomes were prepared as described ear-
lier [11]. In short, liposomes were prepared by lipid film
hydration of a lipid mixture containing 100 μmol of
total lipid. This mixture consisted of gadolinium-diethy-
lenetriaminepentaaceticacid-bis(stearylamide) (Gd-
DTPA-BSA, Gateway Chemical Technology, St. Louis,
MO, USA), 1,2-distearoyl-sn-glycero-3-phosphocholine
(DSPC, Lipoid GmbH, Ludwigshafen, Germany), choles-
terol (Avanti Polar Lipids, Alabaster, AL, USA), 1,2-dis-
tearoyl-sn-glycero-3-phospoethanolamine-N-[methoxy
(poly(ethylene glycol))-2000] (PEG2000-DSPE, Lipoid
GmbH) and 1,2-distearoyl-sn-glycero-3-phospoethanola-
mine-N-[maleimide(poly (ethylene glycol))-2000] (Mal-
PEG2000-DSPE, Avanti Polar Lipids) at a molar ratio of
0.75/1.1/1/0.075/0.075. The resulting vesicles were sized
by extrusion through 200 nm filters (four times), fol-
lowed by extrusion through two 100 nm filters (ten
times). Liposomes were concentrated by centrifugation
at 55000 rpm and 4°C for 1 hour. Finally, liposomes
were resuspended in HEPES-buffered saline (20 mM
HEPES and 135 mM NaCl, pH 7.4) at a concentration
of approximately 70 mM of total lipid.
Characterization
The final total lipid concentration was determined with
a phosphate analysis according to Rouser [12]. Dynamic
light scattering (DLS) was performed at 23°C with a
Malvern ZetaSizer Nano S and the resulting hydrody-
namic diameter of the liposomes was approximately 115
nm. Longitudinal relaxivity r1 at 9.4T was measured in
HEPES-buffered saline at 37°C. For this purpose, T1
measurements were performed on samples with various
concentrations of Gd-DTPA-BSA (0.01-1.25 mM) using
a snapshot-FLASH T1 mapping method [13]. The fol-
lowing parameters were used: scan repetition time = 15
s, TR/TE = 4.0/2.0 ms, a = 15°, Nsegments = 32, slice
thickness = 1 mm. A total of 60 inversion times were
sampled ranging from 72 to 4792 ms.
In vivo measurements
Mice were obtained from a commercial breeder (Charles
River, Paris, France) and housed under controlled condi-
tions. A total of 13 Swiss mice (male, 33 ± 2 g) were
used in this study. In the infarct group (N = 8), mice
underwent ischemia/reperfusion surgery by a 30-minute
ligation of the left anterior descending (LAD) coronary
artery. One day after surgery, CMR was performed, con-
sisting of 3D T1 mapping measurements to assess
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determination of wall- thickening. This was followed
immediately by injection of a liposomal contrast agent
through the tail vein (0.05 mmol Gd/kg). Five control
mice served as control group, in which the same CMR
measurements and contrast agent administration were
performed without previous surgery. Twenty-four hours
post-injection, a second T1 measurement was performed
using the same protocols. The mice were then sacrificed
and the heart was excised to measure the Gd content ex
vivo. The study protocols were approved by the local
animal ethical committee.
CMR was performed with a 9.4 T Bruker experimental
scanner using a 72-mm-diameter volume transmit coil
in combination with a mouse cardiac phased-array sur-
face coil (Bruker BioSpin GmbH, Ettlingen, Germany).
T h el a t t e rc o n s i s t so fa2b y2a r r a yo fs q u a r ec o i le l e -
ments, each sized 16 × 16 mm
2.3 DT 1 mapping was
performed as published previously [10] using retrospec-
tive triggering (3D IntraGate) with variable flip angles.
In the current study, three different flip angles a were
used (a = 2°, 8° and 14°). This was shown to produce
highly reproducible myocardial T1 maps, in which the
95% confidence interval for ΔR1 at baseline values was
only 0.15 s
-1. After pre-contrast T1 measurements, the
same sequence was performed in black-blood mode and
a = 8° for assessing wall thickening values. For this par-
ticular purpose, black-blood was chosen over bright-
blood scans, because of superior wall delineation. On
the other hand, black-blood scans are less suitable for
T1 mapping (see Discussion). Although the use of retro-
spective triggering enables reconstruction of an arbitrary
number of cardiac frames, a sufficient number averages
is needed for each frame. With an imaging time of 20
minutes, reconstruction of 12 cardiac frames provided
good quality black-blood 3D CINE images for determin-
ing wall thickening values from end-diastolic and end-
systolic frames. The total imaging time for each animal
was approximately 90 minutes.
Data analysis
Pre- and post-contrast myocardial 3D T1 maps were
segmented according to the AHA 17-segment model
[14] using a custom-built segmentation algorithm
(Mathematica 7.0, Wolfram Research, Champaign, IL,
USA). Segmentation was based on the high flip angle
T1-weighted scan, in which blood-myocardium contrast
was highest. For each segment, mean pre- and post-con-
trast R1 values were calculated (R1 =1 / T 1), as well as
corresponding ΔR1 values (R1
post -R 1
pre). Additionally,
wall thickness (WT) of all segments was determined
from the black-blood 3D IntraGate scans in both end-
diastolic (ED) and end-systolic (ES) cardiac phases.
Systolic wall thickening (SWT) values were defined as
(WT
ES/WT
ED - 1) * 100%.
Ex vivo Gd quantification
After post-contrast CMR measurements, mice were
sacrificed through cervical dislocation. From all mice in
the infarct group, the heart was excised and stored in
the freezer at -80°C until further use. A mid ventricular
slice containing the infarct area (2.5 mm above the
apex) was then cut from the heart using a mouse heart
slicer (Zivic Instruments, Pittsburgh, PA, USA). The
slice was subsequently cut into four segments (septal,
posterior, lateral and anterior), each of which was
weighed and put in a vial. For all segments, the Gd con-
tent (in nanograms) was determined with ICP-MS. The
Gd concentration ([Gd]) was then calculated in each
segment using the specific gravity of myocardial tissue
(1.05 g/ml) and the molar weight of Gd (157.25 g/mol).
Statistics
Statistical analysis was done with SPSS 17.0 (SPPS, Inc.,
Chicago, IL, USA) and JMP 9.0 (SAS Institute, Cary,
NC, USA). All values are reported as mean ± standard
deviation. All tests were performed on the R1 values,
rather than on T1 values. The level of statistical signifi-
c a n c ew a ss e ta tp=0 . 0 5f o ra l lt e s t s .P r e -a n dp o s t -
contrast R1, as well as ΔR1 values were considered sepa-
rately. For these parameters, significant differences
between infarct, remote and control areas were tested
with a one-way ANOVA and post-hoc Tukey test. Note
that infarct segments were defined as those segments
with a corresponding wall thickening value smaller than
15%, whereas for remote regions, the lower threshold
was set at 45%. Differences in ΔR1 as function of wall
thickening were also tested using a one-way ANOVA
and post-hoc Tukey test. To correlate regional ΔR1
values as estimated from in vivo CMR data with the Gd
concentrations as measured by ex vivo ICP-MS, ortho-
gonal regression was performed. This was preferred over
linear regression, because errors in both measurement
techniques should be taken into account.
Results
Figure 1 shows end-diastolic black-blood images of a
representative mouse of the infarct group in four differ-
ent slices reconstructed from the 3D imaging volume.
The entire CINE series containing all cardiac frames is
provided as a supplemental movie in Additional File 1.
Blood suppression was excellent throughout the whole
3D volume, resulting in good delineation of the cardiac
wall without presence of blood flow artifacts. Typically,
akinetic regions were found in the postero- and antero-
lateral wall.
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cardial T1, as well as corresponding post-contrast T1-
weighted images are shown in Figure 2. Akinetic regions
apparent from Figure 1 can already be distinguished in
the pre-contrast T1 maps (Figure 2A) from an increase
in T1. However, they are more evident in the post-con-
trast images from a large increase in signal intensity
(Figure 2C, arrows) and corresponding significant
decrease in T1 (Figure 2B).
Figure 3A shows Bull’s eye plots of regional values of
ΔR1 (R1
post -R 1
pre) and wall thickening of the same
mouse as in Figure 2. The latter was divided into three
categories, where SWT values < 15% and > 45% were
considered ‘infarcted’ or ‘remote’, respectively [1,15].
Regions of low SWT matched with regions of high ΔR1
v a l u e s ,i n d u c e db yt h ep r e s e n c eo ft h ep a r a m a g n e t i c
liposomes. The mean ΔR1 as function of SWT is plotted
in Figure 3B. ΔR1 decreased rapidly with increasing per-
centage of wall thickening, but only severely infarcted
regions revealed significantly elevated ΔR1 values com-
p a r e dt or e m o t er e g i o n s .F o rc o m p a r i s o n ,S W Ti n
healthy control mice was 65.0 ± 12.3%.
Statistical differences in pre-contrast T1, post-contrast
T1 and ΔR1 between infarct, remote and control regions
are elaborated in Figure 4. For all parameters, there was
a significant difference (p < 0.01) between the infarct
Figure 1 3D black-blood retrospectively triggered CINE images used for determination of wall thickening. 3D black-blood retrospectively
triggered CINE images used for determination of wall thickening. Images from left to right represent different slices through the heart towards
the apex (movie provided in Additional File 1).
Figure 2 Pre-contrast myocardial T1 (A), post-contrast myocardial T1 (B), and post-contrast T1-weighted images (C) in a mouse with
myocardial infarction. Pre-contrast myocardial T1 (A), post-contrast myocardial T1 (B), and post-contrast T1-weighted images (C) in a mouse
with myocardial infarction. Arrows mark infarct regions showing contrast enhancement in post-contrast T1-weighted imaging. Images represent
the same slices as in Figure 1.
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regions on the other hand. In pre-contrast T1 scans, the
mean T1 of infarcted myocardium was elevated (2030 ±
131 ms) as compared to remote (1761 ± 114 ms) and
control values (1667 ± 50 ms). Post-contrast T1 values
were decreased compared to pre-contrast T1 in infarct
(910 ± 107 ms), remote (1400 ± 196 ms) as well as con-
trol (1203 ± 86 ms) regions. T1 was significantly lowest
in the infarcted myocardium. The post- and pre-contrast
longitudinal relaxation rate difference (ΔR1) was largest
for the infarct region (0.60 ± 0.13 s
-1). However, also in
remote tissue and in control animals the contrast agent
resulted in a significant ΔR1 (0.15 ± 0.08 s
-1 and 0.23 ±
0.05 s
-1, respectively, not significantly different). Since
the liposomal contrast agent does not extravasate from
healthy blood vessels, these R1 changes in remote and
control tissues are likely caused by contrast agent still
circulating in the blood 24 hours post injection.
Figure 5 shows the relation between ΔR1 values
determined by in vivo CMR and Gd concentrations
determined by ex vivo ICP-MS. When considering all
segments that were analyzed separately (Figure 5A),
the Pearson correlation coefficient r was 0.6 with R
2 =
0.36. However, a more substantial correlation was
found after averaging values for each heart slice (r =
0.81) with a corresponding R
2 of 0.65 (Figure 5B).
Furthermore, a small but significant offset for ΔR1 was
found in both analyses. The slope is the effective in
vivo relaxivity of the liposomal contrast agent r1 =1 . 0 6
mM
-1s
-1. This was significantly lower than r1 =2 . 2
mM
-1s
-1 (R
2 = 0.99) for the liposomes in suspension in
vitro.
Figure 3 Relation between wall thickening and contrast agent accumulation. (A) Bull’s eye plots of ΔR1 and wall thickening (SWT) values
corresponding to the animal in Figure 1. Regions with SWT < 15% are considered infarcted, whereas remote regions have SWT > 45%. (B)
Relation between wall thickening and their corresponding ΔR1 values (mean value of all animals, * p < 0.01).
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Page 5 of 9Figure 4 Statistical analysis. Statistical analysis of pre-contrast T1, post-contrast T1 and ΔR1 for infarcted, remote and control tissue (* p < 0.01).
Figure 5 Correlation between regional ΔR1 and Gd concentration. Correlation between regional ΔR1 values determined by in vivo CMR and
Gd concentration determined by ex vivo ICP-MS. The analysis was done either on all individual heart segments (A) or after averaging all values
in each heart slice (B).
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In this paper we described the use of 3D T1 mapping to
assess myocardial relaxation rates after ischemia/reper-
fusion injury before and after administration of a liposo-
mal contrast agent. This type of contrast agent is
especially known for its high relaxivity per particle and
long circulation half-life [16], but also for its prolonged
retention in the infarcted tissue, allowing visualization of
the contrast agent many hours after administration
[17-19].
In this study, we chose to perform post-contrast mea-
surements 24 hours after contrast agent injection. The
24 hours time period allowed for sufficient accumulation
of contrast agent in the infarct area, while at the same
time providing sufficient clearance of the contrast agent
from the blood. Similar ΔR1 values in remote and con-
trol tissue however suggested that a small amount of
contrast agent was still present in the blood. At later
time points, full blood clearance would have been
achieved, but probably at the expense of efflux of con-
trast agent from the infarction. Also, it is known that
infarct development and healing is a very dynamic pro-
cess, whereas pre- and post-contrast measurements are
aimed at representing the same infarct status. Therefore
we limited our T1 quantification to the 24 hours time
period. Previous experiments have shown a negligible
mean effect of repeated measurements on R1 [10]. In
future experiments, pre- and post-contrast blood T1
measurements could be incorporated to better quantify
the influence of blood contrast agent concentration
levels on myocardial T1 changes.
The black-blood protocol used in this study for func-
tional measurements could also have been used for
myocardial T1 mapping. However, although black-blood
imaging was very effective in suppressing signal from
the blood (see Figure 1), it does not prevent exchange of
blood magnetization with the myocardium and therefore
does not eliminate contamination of myocardial signal
due to presence of contrast agent in the blood. Also, we
have previously shown that saturation of the blood
results in dramatically lower effective myocardial T1
values [10].
Based on regional ΔR1 values, a significantly higher
uptake of contrast agent was found in infarct regions
compared to remote and control regions. The identifica-
tion of regions being either ‘infarcted’ or ‘remote’ was
based on wall thickening values determined from func-
tional CINE measurements (Fi g u r e1 ) .W ec h o s er a t h e r
conservative threshold values for wall thickening (< 15%
and > 45%) to ensure proper identification of infarct
and remote areas [1,15]. Additionally, it was shown that
the infarct area had a significantly higher T1 value
already in pre-contrast scans. Previously, elevated T1
values in infarcted myocardium have been attributed to
several different mechanisms. Some studies argue that
formation of myocardial edema early after ischemia
results in T1 increase due to a larger fraction of free
water [7,20]. The increased wall thickness in the
infarcted myocardium visible in end-diastolic images
(Figure 1) indeed supports this theory. Others [21] claim
that this increase of myocardial T1 is more likely caused
by a decrease in perfusion, based on iso-intense remote
and infarcted tissue in proton density weighted images.
The use of a surface coil in this study creates a signal
intensity gradient in our cardiac images, which made it
difficult to assess proton density and corroborate or
negate the latter hypothesis.
An ongoing topic within in the field of contrast-
enhanced MR imaging is the actual quantification of
regional contrast agent accumulation. With respect to
small animal cardiac imaging, this is one of few studies
attempting to correlate contrast agent induced ΔR1
values derived from in vivo CMR measurements with
contrast agent concentrations determined by ex vivo
analysis [9]. When analyzing all segments (4 in each
mouse) separately, only a weak correlation was found.
However, a substantial correlation was found when con-
centration values of all four segments within the slice
were averaged. We believe that weak correlation of indi-
vidual segments is caused by inaccuracies in cutting the
heart slices into exactly the same segments as those of
the in vivo CMR. Because of the generally sharp demar-
cations of the infarct, small errors in circumferential
division and sectioning of the left ventricle can therefore
lead to substantial differences in Gd concentrations. We
therefore believe that a significant part of the variation
is caused by inaccuracies of the cutting procedure.
Reproducibility of regional T1 quantification of healthy
myocardium using the current CMR protocol was
demonstrated previously [10]. In the present study, we
found the same myocardial T1 values for the control
group, proving reproducibility of the method across stu-
dies. Ex vivo determined Gd concentrations correlated
fairly well with in vivo ΔR1 values. Taken together, we
therefore conclude that regional quantification of con-
trast agent concentrations is feasible.
At this point, the mechanism of contrast agent accu-
mulation is believed to be passive accumulation
throughout the increased extracellular space by extrava-
sation of the liposomes through leaky vasculature in the
reperfused injured myocardium [22]. Regression analysis
interestingly showed that the effective relaxivity of the
liposomes in vivo was lower compared to that deter-
mined in vitro. Reduced relaxivity could be mediated by
the cellular environment of the myocardium, partial
volume effects or compartmentalization of the liposomes
[23]. Compartmentalization may result from phagocyto-
sis of liposomes by macrophages. Whether or not
Coolen et al. Journal of Cardiovascular Magnetic Resonance 2011, 13:56
http://www.jcmr-online.com/content/13/1/56
Page 7 of 9phagocytosis occurs also depends on the liposomal for-
mulation [18,22]. Future studies could focus on combin-
ing regional quantification of contrast agent
concentrations with more detailed histological analysis
on the cellular level to reveal the exact mechanisms of
uptake. Importantly, in vivo relaxivity values must be
considered for correct estimation of Gd concentrations
from ΔR1 values.
Conclusions
In summary, the quantitative T1 mapping technique
described in this study provides a reproducible tool to
monitor the accumulation of contrast agents in con-
trast-enhanced studies of murine myocardial infarction.
A particular field of applicati o ni st h a to ft a r g e t e dc o n -
trast agents, which are used for mapping the spatial dis-
tribution of specific biomarkers. The contrast agent
relaxivity was found to be lower than that measured in
vitro, which needs consideration when quantifying local
contrast agent concentrations.
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